Page 186 - วารสารกรมการแพทย์แผนไทยฯ ปีที่ 20 ฉบับที่ 1

166 วารสารการแพทย์แผนไทยและการแพทย์ ทางเลือก ปีที่ 20 ฉบับที่ 1 มกราคม-เมษายน 2565

moxibustion on clinical symptoms, peripheral inflam- ernization of Traditional Chinese Medicine and Materia
matory indexes and T lymphocyte subsets in COVID-19 Materia-World Science and Technology. 2020;22(3):622-
patients. Chinese Acupuncture & Moxibustion. 31. (in Chinese)
2020;40(12):1271-5. (in Chinese) 49. Paybast S, Emami A, Koosha M, Baghalha F. Novel
42. Huang X, Xie D, Qiu Q, Shen Y, Jiao L, Li Q, Chen coronavirus disease (COVID-19) and central nervous
R. Clinical observation of heat-sensitive moxibustion system complications: What neurologist need to know.
treatment for coronavirus disease 2019. Chinese Acu- Acta Neurol Taiwan. 2020;29(1):24-31.
puncture & Moxibustion. 2020;40(6):576-80. (in Chinese) 50. Sun S, Liang T, Lu Y, Huang X, Geng S, Ma L, Xu L.
43. Huo Z, Liu Y, Hao L, Wang Y, He Y, Zhou S, Yan K. Study on the effects of Langchuangqing granule on
Research progress on potential application of Huoxiang systemic lupus erythematosush in animals. Chin J Clin
Zhengqi in prevention and treatment of coronavirus Pharmacol. 2016;32(12):1125-8. (in Chinese)
disease 2019. Drugs and Clinic. 2020;35(3):405-10. (in 51. Chen G, Guang H, Li L, YE Q, Cheng LV, Yang Y, Aiping
Chinese) L.Biological network analysis on mechanism of Lianhua
44. Deng Y, Liu B, He Z, Liu T, Zheng R, Yang A, Huang A, Qingwen granules/capsules for H1N1 influenza A. J
Li Y, Xu Y. Study on active compounds from Huoxiang Tradit Chin Med. 2014;55(8):703-7.
Zhengqi oral liquid for prevention of coronavirus disease 52. Zhang W, Zhang J. Application progress of Shufeng
2019 (COVID-19) based on network pharmacology and Jiedu capsule in clinical disease treatment. Capital Food
molecular docking. Chinese Traditional and Herbal Medicine. 2019;26(16):11-2. (in Chinese)
Drugs. 2020;51(5):1113-22. (in Chinese) 53. Xia J, Rong L, Sawakami T, Inagakia Y, Song P, Hasega-
45. Zhou W, Zhang M, Yan Y, Wang S, Peng T, Li Y, Chai waa K, Sakamoto Y, Tang W. Shufeng Jiedu capsule and
Z. Molecular mechanism of Huoxiang (Pogostemonis its active ingredients induce apoptosis, inhibit migration
Herba) in treatment of corona virus disease 2019 (CO- and invasion, and enhances doxorubicin therapeutic
VID-19) based on network pharmacology and molecular efficacy in hepatocellular carcinoma. Biomed Pharma-
docking. Journal of Practical Traditional Chinese Internal cother. 2018;99:921-30.
Medicine. 2020;34(9):1-8. (in Chinese) 54. Sawakami T, Xia JF, Song PP. Researchers of chronic
46. He Z, Luo P, Gao X, Jiang Y, Bi J, Tang X. Research obstructive pulmonary disease gathered at the 2017
progress of novel coronavirus pneumonia (COVID-19) Japan-China joint medical workshop on aging and
from natural products of traditional Chinese medicine. health. Biosci Trends. 2017;11(6):706-9.
World Notes on Antibiotics. 2020;41(4):274-82. (in Chi- 55. Zhao J, Tian SS, Yang J, Liu JF, Zhang WD. Investigat-
nese) ing mechanism of Qing-Fei-Pai-Du-Tang for treatment
47. Gong P, Guo Y, Li X, Wang N, Gu J. Exploring active of COVID-19 by network pharmacology. Chin. Trad.
compounds of Jinhua Qinggan granules for prevention Herbal Drugs. 2020;4(51):829-35. (in Chinese)
of COVID-19 based on network pharmacology and mo- 56. Rojas Á, Campo JAD, Clement S, Lemasson M, García-
lecular docking. Chinese Traditional and Herbal Drugs. Valdecasas M, Gil-Gómez A, Ranchal I, Bartosch B,
2020;51(7):1685-93. (in Chinese) Bautista JD, Rosenberg AR, Negro F, Romero-Gómez
48. Shen F, Fu Z, Wu Y, Kuang G. The potential molecular M. Effect of quercetin on hepatitis C virus life cycle:
mechanism of active compounds binding SARS- from viral to host targets. Sci Rep. 2016;6:31777.
CoV-2 specific target proteins in Huaqing granules 57. Stux G, Pomeranz B. Basics of Acupuncture. 4th ed.
treat COVID-19 based on network pharmacology and Berlin: Springer-Verlag; 1998.
high-throughput molecular docking fellowship. Mod-